Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2010
03/11/2010CA2735842A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010CA2735794A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010CA2735782A1 Heterocyclic pim-kinase inhibitors
03/11/2010CA2735779A1 Bicyclic kinase inhibitors
03/11/2010CA2735773A1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
03/11/2010CA2735770A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
03/11/2010CA2735764A1 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
03/11/2010CA2735208A1 Novel benzamides, production thereof, and use thereof as medicaments
03/11/2010CA2734415A1 Picolinamide derivatives as kinase inhibitors
03/11/2010CA2733533A1 Hedgehog pathway modulators
03/10/2010EP2161265A2 Compounds having selective inhibiting effect at GSK3
03/10/2010EP2161258A2 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
03/10/2010EP2160387A2 Heteroarylamide pyrimidone compounds
03/10/2010EP2160386A1 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
03/10/2010EP2160373A1 BENZO[a]FLUORANTHENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME
03/10/2010EP2160187A1 Spiroindalones
03/10/2010EP2029558B1 Compounds and methods for modulating fxr
03/10/2010EP1841737B1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
03/10/2010EP1786801B1 2-arylcarbamoyl-indoles as cytokine inhibitors
03/10/2010EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/10/2010EP1377293B1 Aryl and biaryl piperidines used as mch antagonists
03/10/2010CN101668755A Therapeutic agents useful for treating pain
03/10/2010CN101665485A Triazole derivative, and light-emitting element, light-emitting device, and electronic device using triazole derivative
03/10/2010CN101665484A Method for preparing lenalidomide
03/09/2010US7674936 For agriculture crops
03/09/2010US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators
03/09/2010US7674903 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
03/09/2010US7674887 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
03/09/2010US7674828 Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions
03/09/2010US7674818 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
03/09/2010US7674805 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
03/09/2010US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
03/09/2010US7674796 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
03/09/2010US7674795 Fluorene derivatives, composition containing said derivatives and the use thereof
03/09/2010US7674474 Pesticidal agents on the basis of 1-aryl-aminopyrrol
03/09/2010CA2537598C Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/09/2010CA2431952C Muscarinic antagonists
03/09/2010CA2421819C Isoquinolinone potassium channel inhibitors
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2379282C Amido spiropiperidines promote the release of growth hormone
03/09/2010CA2329292C A process for the manufacture of sulfonylaminocarbonyl triazolinones and salts thereof under ph controlled conditions
03/09/2010CA2140598C Prolineamide derivatives
03/04/2010WO2010025436A2 Nitrogen and sulfur-containing heterocycle derivatives
03/04/2010WO2010025370A2 Preparation of ranolazine
03/04/2010WO2010025197A1 Process for preparing certain cinnamide compounds
03/04/2010WO2010025138A2 Pyrimidine compounds
03/04/2010WO2010024451A1 Pyrrole compounds
03/04/2010WO2010024430A1 2,4-diaminopyrimidine compound
03/04/2010WO2010023931A1 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same
03/04/2010WO2010023678A1 A process for preparation of rosuvastatin intermediate
03/04/2010WO2010023512A1 Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them
03/04/2010WO2010023445A1 Novel potassium channel blocker
03/04/2010WO2010004198A3 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolinξ, preparation thereof, and therapeutic use thereof
03/04/2010WO2009156860A3 4-(pyridin-4-yl)-1h-(1, 3, 5)triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases
03/04/2010WO2009143211A3 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
03/04/2010WO2009117484A3 Small molecule e2f inhibitor
03/04/2010WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity
03/04/2010US20100056795 Novel intermediate and process useful in the preparation of -(2-chlorophenyl)-methanone
03/04/2010US20100056784 Process for the preparation of voriconazole
03/04/2010US20100056602 Substituted Pyrrole Derivatives And Their Use As HMG-CO Inhibitors
03/04/2010US20100056582 Modulators of LXR
03/04/2010US20100056577 Pyrrole compounds
03/04/2010US20100056576 Kinase inhibitors and methods of their use
03/04/2010US20100056573 2-alkyl-indazole compounds for the treatment of certain cns-related disorders
03/04/2010US20100056571 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
03/04/2010US20100056569 Heterocyclic Non-Nucleoside Compounds, Their Preparation, Pharmaceutical Composition And Their Use As Antiviral Agents
03/04/2010US20100056567 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
03/04/2010US20100056566 New substituted isoquinoline and isoquinolinone derivatives
03/04/2010US20100056541 Biphenyl compounds useful as muscarinic receptor antagonists
03/04/2010US20100056531 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
03/04/2010US20100056530 Glucokinase activators
03/04/2010US20100056522 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient
03/04/2010US20100056521 (aza)indole derivative and use thereof for medical purposes
03/04/2010US20100056515 Benzimidazole compounds
03/04/2010US20100056509 Heteroaryl sulfonamides and ccr2
03/04/2010US20100056506 Substituted 2-amino-fused heterocyclic compounds
03/04/2010US20100056505 Substituted Pyrazalones
03/04/2010US20100056501 Substituted lactams as inhibitors of abeta protein production
03/04/2010US20100056498 Substituted monocyclic cgrp receptor antagonists
03/04/2010US20100056497 Amide derivative
03/04/2010US20100056490 Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors
03/04/2010US20100056374 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
03/04/2010US20100055071 Anti-Viral Compounds
03/04/2010US20100053724 Electrochromic materials and electrochromic devices using the same
03/04/2010US20100052526 Pyrene compounds and organic electroluminescent devices using the same
03/04/2010CA2735730A1 2,4-diaminopyrimidine compound
03/04/2010CA2735162A1 Pyrrole compounds
03/04/2010CA2733606A1 Process for preparing certain cinnamide compounds
03/03/2010EP2158197A1 Method for the preparation of high purity almotriptan
03/03/2010EP2158195A1 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders
03/03/2010EP2158194A2 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics
03/03/2010EP2081572B1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
03/03/2010EP2018375B1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
03/03/2010EP1753719B1 Substituted pyrrolidine-2-ones
03/03/2010EP1542969B1 Pyrrolidone derivatives as maob inhibitors
03/03/2010EP1505973B1 Combinations for treating multiple myeloma
03/03/2010EP1107964B1 Isoquinoline derivatives with angiogenesis inhibiting activity
03/03/2010CN101663293A Quinoline-carboxamide derivatives as p2y12 antagonists
03/03/2010CN101663292A 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
03/03/2010CN101663291A Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
1 ... 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 ... 1080